Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine

被引：15

作者：

Ballou, W. Ripley ^{[1
]}

机构：

[1] GlaxoSmithKline, Worldwide Clin Dev, B-1330 Rixensart, Belgium

来源：

MICROBES AND INFECTION | 2007年 / 9卷 / 06期

关键词：

malaria; sporozoite; attenuated; subunit; vaccine;

D O I：

10.1016/j.micinf.2007.02.006

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Attenuated pre-erythrocytic stage malaria vaccines protect humans from sporozoite challenge. Current technology limits the feasibility of their commercial scale production and poses a significant risk of contamination with transmissible agents. Overcoming these barriers will be very challenging. In contrast, subunit vaccines appear quite feasible and show great promise as candidate malaria vaccines. (C) 2007 Elsevier Masson SAS. All rights reserved.

引用

页码：761 / 766

页数：6

共 30 条

[1] Complete development of mosquito phases of the malaria parasite in vitro [J].

Al-Olayan, EM ;

Beetsma, AL ;

Butcher, GA ;

Sinden, RE ;

Hurd, H .

SCIENCE, 2002, 295 (5555) :677-679

[2] Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children:: single-blind extended follow-up of a randomised controlled trial [J].

Alonso, PL ;

Sacarlal, J ;

Aponte, JJ ;

Leach, A ;

Macete, E ;

Aide, P ;

Sigauque, B ;

Milman, J ;

Mandomando, I ;

Bassat, Q ;

Guinovart, C ;

Espasa, M ;

Corachan, S ;

Lievens, M ;

Navia, MM ;

Dubois, MC ;

Menendez, C ;

Dubovsky, F ;

Cohen, J ;

Thompson, R ;

Ballou, WR .

LANCET, 2005, 366 (9502) :2012-2018

[3] Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial [J].

Alonso, PL ;

Sacarlal, J ;

Aponte, JJ ;

Leach, A ;

Macete, E ;

Milman, J ;

Mandomando, I ;

Spiessens, B ;

Guinovart, C ;

Espasa, M ;

Bassat, Q ;

Aide, P ;

Ofori-Anyinam, O ;

Navia, MM ;

Corachan, S ;

Ceuppens, M ;

Dubois, MC ;

Demoitié, MA ;

Dubovsky, F ;

Menéndez, C ;

Tornieporth, N ;

Ballou, WR ;

Thompson, R ;

Cohen, J .

LANCET, 2004, 364 (9443) :1411-1420

[4]

Ballou WR, 2004, AM J TROP MED HYG, V71, P239

[5] Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites [J].

Bejon, P ;

Andrews, L ;

Andersen, RF ;

Dunachie, S ;

Webster, D ;

Walther, M ;

Gilbert, SC ;

Peto, T ;

Hill, AVS .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (04) :619-626

[6] Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment [J].

Belnoue, E ;

Costa, FTM ;

Frankenberg, T ;

Vigário, AM ;

Voza, T ;

Leroy, N ;

Rodrigues, MM ;

Landau, I ;

Snounou, G ;

Rénia, L .

JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2487-2495

[7] Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells [J].

Berenzon, D ;

Schwenk, RJ ;

Letellier, L ;

Guebre-Xabier, M ;

Williams, J ;

Krzych, U .

JOURNAL OF IMMUNOLOGY, 2003, 171 (04) :2024-2034

[8] HUMORAL IMMUNE-RESPONSES IN VOLUNTEERS IMMUNIZED WITH IRRADIATED PLASMODIUM-FALCIPARUM SPOROZOITES [J].

EGAN, JE ;

HOFFMAN, SL ;

HAYNES, JD ;

SADOFF, JC ;

SCHNEIDER, I ;

GRAU, GE ;

HOLLINGDALE, MR ;

BALLOU, WR ;

GORDON, DM .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 49 (02) :166-173

[9] Plasma for fractionation: safety and quality issues [J].

Farrugia, A .

HAEMOPHILIA, 2004, 10 (04) :334-340

[10] Immunity to non-cerebral severe malaria is acquired after one or two infections [J].

Gupta, S ;

Snow, RW ;

Donnelly, CA ;

Marsh, K ;

Newbold, C .

NATURE MEDICINE, 1999, 5 (03) :340-343

← 1 2 3 →